Document is current
Any future updates will be listed below
-
Authors
Song, Dingyun https://orcid.org/0000-0002-7723-7503
Li, Zhongwen
Sun, Faguo
Wu, Kaiwei
Zhang, Kan
Liu, Wenjing
Liu, Kaidi
An, Bin
Wang, Zai
Zhao, Tiemei
Chen, Huaiyong
Xiao, Li
Wang, Liu
Xie, Lixin
Li, Wei
Peng, Liang
Hao, Jie
Wu, Jun
Dai, Huaping
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 92068108, No. 82370072, No. 32370851)
National Key Research and Development Program (2023YFC3605100, 2020YFA0804000, 2021YFA1101600)
the international cooperation project of China Manned Space Program, the International Partnership Program of Chinese Academy of Sciences (No. 152111KYSB20160004)
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 18 September 2024
First Online: 8 October 2024
Declarations
:
: For animal experiments, the study entitled “Therapeutic effect of human embryonic stem cell derived mesenchymal stem cells on bleomycin induced pulmonary fibrosis in mice” was approved by the Experimental Animal Ethics Committee of China-Japan Friendship Hospital (Date: 27. 02. 2019, No.190108) and performed according to the Beijing Laboratory Animal Management Ordinance, guidelines. Our study involves IMRCs lines, therefore ethics approval is not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
